BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3190905)

  • 1. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
    Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 6. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Muscular dystrophies].
    Zellweger H; Ionasescu V; Conway TW
    Schweiz Med Wochenschr; 1972 Jun; 102(22):753-9. PubMed ID: 5035931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M; Rivron M; Landrieu P
    Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrocardiograms and plasmatic enzymes (SGOT, SGPT, ALD, LDH, CPK) in experimental myocardial infarct in the dog].
    Lombardo G; Tamburino G; Parano G; Casaccio F; Montemagno S
    Biol Lat; 1967; 20(1):75-86. PubMed ID: 5593456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution on the study of pseudohypertrophic muscular dystrophies. II. Pseudohypertrophic muscular dystrophies in females].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):116-35. PubMed ID: 5800953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF; Droznina TA; Markelov IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence against the existence of a subclinical form of X-linked Duchenne muscular dystrophy.
    Emery AE; Spikesman A
    J Neurol Sci; 1970 Jun; 10(6):523-33. PubMed ID: 5422556
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
    Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.